Ignite Creation Date:
2024-07-17 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06487585
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-05
First Post:
2024-06-27
Brief Title:
ANG-First Trial Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery
Sponsor:
University of Maryland St Joseph Medical Center
Organization:
University of Maryland St Joseph Medical Center
Study Overview
Official Title:
Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery ANG-First Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this research is to evaluate the use of Angiotensin II in patients with low blood pressure post-surgery Your information will be collected for 28 days post the procedure and initiation of the study drug to assess for safety events and complications
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None